Pepsin is the primary protein-digesting enzyme in the human stomach, responsible for breaking dietary proteins into smaller fragments so they can be absorbed further along the digestive tract. It works in an environment most enzymes would never survive: the powerfully acidic gastric fluid, with a pH between roughly 1 and 3. Beyond digestion, pepsin turns up in surprising medical contexts, from reflux damage in the throat and lungs to blood tests that screen for stomach cancer. The enzyme is also recognized as the first enzyme ever identified, a distinction that anchors it in the history of biochemistry.
How Pepsin Gets Made and Switched On
Your stomach does not produce pepsin directly. Instead, specialized cells in the stomach lining release an inactive precursor called pepsinogen. This is a safety measure: if the enzyme were active the moment it left the cell, it could digest the very tissue that made it. Pepsinogen sits harmlessly until it encounters the hydrochloric acid secreted by neighboring cells. When the pH drops low enough, pepsinogen undergoes a rapid structural change. Research has shown that upon acidification, pepsinogen is quickly converted into an intermediate form, which then folds so that a portion of the molecule slots into its own active site, essentially allowing it to cut itself into the active enzyme pepsin plus a small leftover fragment called the activation peptide.1Journal of Biological Chemistry. Mechanism of intramolecular activation of pepsinogen. Evidence for an intermediate delta and the involvement of the active site of pepsin in the intramolecular activation of pepsinogen. At very low pH values (around 1 to 3), this activation happens as an intramolecular event, meaning a single pepsinogen molecule transforms on its own without needing help from an existing pepsin molecule. At slightly higher pH (around 4), some bimolecular activation also occurs, where an already-active pepsin molecule helps convert a neighboring pepsinogen.2Journal of Biological Chemistry. The spontaneous and pepsin-catalyzed activation of pepsinogen
Once activated, pepsin gets to work cleaving proteins. It belongs to the aspartic protease family, a group of enzymes that use two aspartic acid residues in their active site to catalyze the breaking of peptide bonds. Pepsin prefers to cut next to large, bulky amino acids like leucine and phenylalanine. While that preference is consistent, its behavior at other positions is harder to predict, which gives the enzyme a broad but somewhat fuzzy specificity.3PubMed Central. Accessing the Reproducibility and Specificity of Pepsin and other Aspartic Proteases This broad specificity is actually useful: pepsin does not need to be picky, because its job is to chop proteins into manageable pieces rather than make precise surgical cuts. The more refined work of protein digestion happens downstream, in the small intestine, where pancreatic enzymes with narrower specificity finish the job.
Why Stomach Protein Digestion Matters
Pepsin’s role as the stomach’s main protease is not just about breaking down protein for energy. The gastric stage of digestion sets the pace for everything that follows. The interaction between pepsin and food proteins is the first step in protein hydrolysis, and it shapes the rate at which amino acids are eventually released and how allergenic the proteins remain as they move through the gut.4PubMed. Digestion of food proteins: the role of pepsin If pepsin does a thorough job in the stomach, the small intestine receives fragments that are easier and faster to process. If pepsin is impaired, as it is in people taking strong acid-suppressing medications, some protein digestion slows down noticeably.
There is also a direct link between pepsin activity and the absorption of certain micronutrients. Vitamin B12 in food is typically bound to protein. Pepsin is needed to free the vitamin from that protein matrix so it can be picked up by transport molecules further along the digestive tract. Studies have shown that peptic activity is important for food B12 absorption, meaning people who produce little pepsin may be at higher risk for B12 deficiency even if their diet is adequate.5The American Journal of Clinical Nutrition. Effect of Pepsin on the Absorption of Food Vitamin B12 and Iron This is one reason long-term use of proton pump inhibitors (PPIs) has been linked to lower B12 levels: by raising stomach pH, PPIs impair the acid-dependent activation of pepsin, which in turn slows the hydrolytic digestion of proteins and the liberation of bound nutrients.6PubMed. Effects of proton pump inhibitors on gastric emptying: a systematic review
How Food Preparation Changes Pepsin’s Effectiveness
The proteins you eat do not all respond to pepsin the same way. Cooking, fermenting, and other processing methods alter protein structure in ways that either help or hinder pepsin’s ability to break them down. Heated meat proteins, for instance, undergo denaturation and conformational changes that open them up and make them easier for pepsin to attack. Milk proteins are a particularly interesting case. Under gastric conditions, they coagulate to form a curd, which affects how quickly the stomach empties and how thoroughly proteins are hydrolyzed. Heat-treated milk forms a looser curd, which lets pepsin access the protein more readily than the tighter curd formed from raw milk.4PubMed. Digestion of food proteins: the role of pepsin
Processing can also change how allergenic a protein is. When pepsin efficiently degrades a protein in the stomach, fewer intact allergenic fragments reach the intestine, where they might trigger an immune response. Conversely, proteins that resist pepsin digestion tend to be more likely to cause food allergies. This relationship between pepsin susceptibility and allergenicity is one of the factors regulators consider when assessing the safety of novel food proteins.
How Your Stomach Protects Itself
If pepsin can break down proteins, why doesn’t it digest the stomach itself? The short answer: it tries, and the stomach fights back with a remarkably effective defense system. The stomach lining is coated with a continuous layer of mucus gel, and cells at the surface secrete bicarbonate into this layer. Together, the mucus and bicarbonate create a pH gradient. At the surface of the stomach lining, the pH is near-neutral even though the lumen a few millimeters away may be below pH 2.7PubMed. Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin Pepsin is essentially inactive at neutral pH, so the near-neutral zone next to the cells renders it harmless. At the same time, the mucus layer physically blocks pepsin from reaching the epithelial surface, acting as a barrier to the enzyme even when it is still active in the acidic luminal fluid above.8PubMed. The role of mucus in the protection of the gastroduodenal mucosa
Under normal conditions, this mucus-bicarbonate barrier is enough. The trouble starts when the barrier breaks down. In people with peptic ulcer disease, the proportion of a particularly aggressive form of the enzyme, pepsin 1, rises dramatically in gastric juice. Pepsin 1 can be four to five times more active than usual and has greatly increased ability to degrade the protective mucus itself, especially at pH values between 2 and 5. Structural analysis of the mucus layer in ulcer patients shows that the gel-forming mucin polymer is deficient, consistent with being chewed up by the excess pepsin activity.9PubMed. Pepsins and the mucus barrier in peptic ulcer disease The old clinical adage “no acid, no pepsin, no ulcer” captures this relationship: both acid and pepsin are needed to damage the stomach wall once its defenses are compromised.
Pepsin Outside the Stomach
One of the more surprising findings in recent decades is that pepsin causes damage well beyond the stomach. When gastric contents reflux upward, pepsin can reach the esophagus, throat, and even the airways. In the esophagus, the combination of acid and pepsin is what produces the tissue injury seen in reflux esophagitis. But research has now shown that in the larynx and airways, pepsin can cause harm even in the absence of strong acid. The enzyme adheres to laryngeal cells, depletes their defenses, and continues to cause damage internally after being taken up by the cells through endocytosis.10PubMed Central. Reflux revisited: advancing the role of pepsin. This matters because many people with laryngeal reflux symptoms do not test positive for acid reflux on traditional pH monitoring. Pepsin, not acid, appears to be the main culprit in these cases.
In the lungs, the presence of pepsin has become a useful marker for aspiration, the accidental inhalation of stomach contents. Detecting pepsin in bronchoalveolar lavage fluid has been investigated as a way to diagnose reflux-related aspiration in both adults and children. In adults with suspected aspiration pneumonia, pepsin levels above a certain threshold were associated with roughly nine-fold higher odds of aspiration compared to patients without it.11Pulmonology. Bronchoalveolar lavage (BAL) amylase and pepsin levels as potential biomarkers of aspiration pneumonia In children with chronic cough and known gastroesophageal reflux, finding pepsin in lung fluid suggests that reflux-related aspiration may be contributing to their respiratory symptoms, potentially guiding decisions about anti-reflux surgery.12Journal of Pediatric Surgery. Pepsin in bronchoalveolar lavage fluid: a specific and sensitive method of diagnosing gastro-oesophageal reflux–related pulmonary aspiration
Pepsinogen as a Blood Test for Stomach Disease
Because pepsinogen is released into the blood as well as the stomach, a simple blood draw can provide information about what is happening in the gastric lining. There are two main types of pepsinogen in the blood: pepsinogen I (PG I) and pepsinogen II (PG II). A drop in PG I levels, or a drop in the PG I/PG II ratio, signals that the acid-producing part of the stomach lining has atrophied, a condition that raises the risk of stomach cancer. In a large nested case-control study using data from a U.S. cancer screening trial, individuals with abnormal pepsinogen levels had about a tenfold increased risk of gastric cancer after adjusting for infection with H. pylori and other factors. The association was strongest for cancers arising outside the cardia (the top portion of the stomach), where abnormal pepsinogen status was linked to an 11-fold increase in risk.13Cancer Epidemiology, Biomarkers & Prevention. Serum Pepsinogen as a Biomarker for Gastric Cancer in the United States: A Nested Case–Control Study Using the PLCO Cancer Screening Trial Data
More recently, pepsinogen blood tests have also shown promise in identifying autoimmune metaplastic atrophic gastritis (AMAG), a condition in which the immune system attacks the stomach’s acid-producing cells. In patients with AMAG, PG I levels and the PG I/PG II ratio are markedly lower than in healthy controls, and a combination of both markers achieved very high specificity for distinguishing patients with AMAG from those without it.14PubMed Central. Serum pepsinogen â… and the pepsinogen â… /â…¡ ratio as a non-invasive predictive marker for autoimmune metaplastic atrophic gastritis These tests are already used widely in East Asian countries for population-level gastric cancer screening, and interest in adopting them more broadly continues to grow.
Salivary Pepsin Tests for Reflux
The idea of testing saliva for pepsin as a non-invasive way to diagnose gastroesophageal reflux disease (GERD) has generated considerable excitement, but the evidence so far is a mixed bag. When stomach contents reach the throat, pepsin can end up in saliva. Several studies have found that patients with various forms of reflux disease, including erosive esophagitis, non-erosive reflux disease, and Barrett’s esophagus, have significantly higher rates of pepsin in their saliva compared to healthy people. In one study, salivary pepsin was positive in about 72% of non-erosive reflux patients, compared to only 44% who tested positive on traditional 24-hour pH monitoring, suggesting the saliva test may catch cases that standard acid measurements miss.15Journal of Neurogastroenterology and Motility. Salivary Pepsin as an Intrinsic Marker for Diagnosis of Sub-types of Gastroesophageal Reflux Disease and Gastroesophageal Reflux Disease-related Disorders
However, when the overall accuracy of the test is pooled across multiple studies, the numbers are less impressive. A meta-analysis found that salivary pepsin testing for GERD had pooled sensitivity of about 60% and pooled specificity of about 71%, meaning it misses a substantial fraction of people who have the disease and also incorrectly flags some who do not.16PubMed Central. Pepsin in Saliva as a Diagnostic Marker for Gastroesophageal Reflux Disease: A Meta-Analysis The test is commercially available and is sometimes marketed to patients, but its current diagnostic accuracy is not high enough to reliably confirm or rule out GERD on its own. It may still have value as a quick screening tool or as a supplement to other tests, especially in patients with atypical reflux symptoms affecting the throat or airways.
Pepsin in Infant Digestion
Babies do not digest protein the same way adults do. The infant stomach produces less acid and less pepsin than an adult’s, and the gastric environment is generally less harsh during the first months of life. This is a feature, not a bug: breast milk and infant formula deliver proteins in forms suited to an immature digestive system. But the lower pepsin activity means that certain intact protein fragments survive the stomach and reach the intestine, which can influence immune development and the likelihood of developing food allergies. The distinct patterns of proteolysis in infants compared to adults are shaped by differences in food intake and digestive physiology that persist through roughly the first two years of life.17PubMed Central. Protein Digestion of Baby Foods: Study Approaches and Implications for Infant Health. – Section: Abstract Understanding how pepsin activity changes during early development is one of the reasons food scientists put so much effort into studying how baby foods are digested under simulated infant gastric conditions, rather than just applying adult digestion models.
An Evolutionary Perspective on Pepsin
Pepsin is not unique to humans. Pepsinogen genes have been found across the vast majority of vertebrates that have stomachs, from sharks and bony fish to amphibians, reptiles, birds, and mammals. Recent research identified pepsinogen genes in cartilaginous fish (like sharks and rays) for the first time, establishing that the pepsin-based digestive system originated in the last common ancestor of all jawed vertebrates.18Scientific Reports. Molecular evolution of aspartic protease gene family in vertebrates And the link between pepsin and the stomach is remarkably tight: in species that have independently lost their stomachs over evolutionary time (certain fish, for example), the pepsinogen genes are consistently absent as well.19PubMed Central. Recurrent gene loss correlates with the evolution of stomach phenotypes in gnathostome history Losing the stomach means losing pepsin, and vice versa. There does not appear to be a case of a vertebrate that kept pepsinogen genes but discarded the stomach.
The number of pepsinogen genes varies wildly between species. Some fish have just two or three, while certain mammals carry dozens. This variation reflects repeated gene duplication events followed by selective retention or loss in different lineages. One family of pepsinogen genes, pepsinogen C, diversified extensively before the major vertebrate groups diverged, producing gene lineages that were then kept or discarded by different classes. Amphibians and marsupials retained versions that eutherian mammals (like us) lost. Birds kept one lineage but dropped another that reptiles held onto.20PLOS ONE. The Evolution of Pepsinogen C Genes in Vertebrates: Duplication, Loss and Functional Diversification All of this gene shuffling speaks to how central pepsin-based digestion has been to vertebrate survival: the system has been modified and tinkered with over hundreds of millions of years, but its core logic has persisted.
Pepsin’s Structural Cousins and Drug Design
Pepsin belongs to a larger family of aspartic proteases that share a similar structural fold, and this family includes enzymes with medical relevance far outside the stomach. The HIV-1 protease, the enzyme the virus uses to process its own proteins and that is targeted by a major class of antiretroviral drugs, operates using the same fundamental catalytic mechanism as pepsin: two aspartic acid residues cooperating to break a peptide bond. Structural studies have shown that specific residues in pepsin’s active site are equivalent to key residues in HIV-1 protease, and the way inhibitors bind to the two enzymes is strikingly similar.21PubMed Central. Interactions of different inhibitors with active-site aspartyl residues of HIV-1 protease and possible relevance to pepsin
Beyond static structure, the enzymes also share a dynamic mechanism. The large-scale protein motions that modulate enzymatic activity in pepsin-like proteases (a rotation of one lobe relative to another that adjusts how tightly the substrate is held) turn out to be conserved across both the eukaryotic pepsin family and the retroviral proteases. This suggests that aspartic proteases were evolutionarily selected not just for having the right chemical groups in the right place, but for possessing the right kind of structural flexibility.22PubMed. Evolutionarily conserved functional mechanics across pepsin-like and retroviral aspartic proteases Understanding pepsin’s structure and dynamics has thus contributed directly to the design of drugs targeting distant relatives in the same enzyme family, a connection that would have been impossible to predict when pepsin was first described in the 1830s as the first enzyme known to science.23Handbook of Proteolytic Enzymes. Pepsin A